Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,8811,900 of 20,252 grants

Active NON-SBIR/STTR RPGS
The role of flavor in the substitutability of e-cigarettes for combustible cigarettes among persistent smokers
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2027

PROJECT SUMMARY The average smoker will attempt to quit smoking at least 30 times before abstaining for 12 months or longer. These attempts typically occur over decades of smoking,...

$6.13M
USD
Completed TRAINING, INDIVIDUAL
Defining the tumor suppressive mechanism of the kinase STK25
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2024 – 2026

Abstract The maintenance of cellular and tissue homeostasis relies on the tight regulation of cell growth and proliferation. This regulation is predominantly controlled by two evol...

$489.7K
USD
Active NON-SBIR/STTR RPGS
Mechanistic and structural insights into a new pro-metastatic collagen glucosyltransferase
NATIONAL CANCER INSTITUTE University of Kentucky United States 2024 – 2028

Lung cancer is the primary cause of cancer death in western countries, including the United States. Kentucky leads the nation both in lung cancer incidence and mortality. Lung canc...

$5.94M
USD
Active NON-SBIR/STTR RPGS
FBXL16 as a novel factor in promoting endocrine therapy resistance and metastasis of ER+ breast cancer
NATIONAL CANCER INSTITUTE Wright State University United States 2024 – 2026

Project summary Endocrine therapy (ET) resistance and metastasis are major obstacles for curing patients with advanced ERα+ breast cancer (ER+ BC). Upregulated oncogenic ERα activi...

$4.5M
USD
Completed NON-SBIR/STTR RPGS
Improving Accuracy of Next-Generation Microscopy for Early Stage Metastatic Melanoma Detection
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2025

Our focus is on translation of a novel microscopy approach, femtosecond pump-probe microscopy, which our preliminary data shows can determine which (nominally) early-stage primary...

$2.18M
USD
Completed NON-SBIR/STTR RPGS
Development of adverse event (AE) derived biomarkers for predicting clinical outcomes in lung cancer
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT Adverse event (AE) is a critical component of clinical trial for safety data to protect patients from unnecessary risk and to develop safety profile of the...

$1.97M
USD
Completed NON-SBIR/STTR RPGS
Exosome-mediated therapy for liver cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2025

Hepatocellular carcinoma (HCC) is the most common primary liver cancer that represents the second most common cause of cancer-related death worldwide. In addition, the liver the mo...

$2.3M
USD
Active NON-SBIR/STTR RPGS
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)
NATIONAL CANCER INSTITUTE Seattle Inst for Biomedical/Clinical Res United States 2024 – 2028

PROJECT SUMMARY/ABSTRACT A decrease in muscle mass and function, known as sarcopenia, is highly prevalent in cancer patients and often leads to decreased endurance, increased fatig...

$6.52M
USD
Active NON-SBIR/STTR RPGS
The role of pyruvate kinase as a therapeutic target in T-ALL
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2024 – 2028

ABSTRACT T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy that occurs primarily in children but can also occur in adults. Despite recent advances...

$3.59M
USD
Completed NON-SBIR/STTR RPGS
A novel uterine leiomyosarcoma mouse model for therapeutic development
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2025

Title: A novel uterine leiomyosarcoma mouse model for therapeutic development PROJECT SUMMARY: Uterine leiomyosarcoma is an extremely rare but clinically aggressive uterine cancer...

$2.27M
USD
Active NON-SBIR/STTR RPGS
Dissemination of a breast reconstruction decision tool through social media and online communities
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2028

PROJECT SUMMARY Breast reconstruction after mastectomy is critical to comprehensive breast cancer treatment because it can restore quality of life and body image, which are often i...

$5.77M
USD
Active NON-SBIR/STTR RPGS
Merkel cell polyomavirus HLA class I epitopes for generating therapeutic T cell-based cancer immunotherapy
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2028

Summary Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with an incidence of 3,000 USA cases/year. MCC carries a 2-year mortality of 40% with clear unmet medical nee...

$7.35M
USD
Active NON-SBIR/STTR RPGS
Cytokine-mediated regulation of immunity and microenvironment in colorectal cancer metastasis
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2024 – 2028

PROJECT SUMMARY/ABSTRACT Colorectal cancer (CRC) is a second cause of cancer-related mortality because of metastatic disease represented by liver and peritoneal metastasis. This di...

$6.82M
USD
Completed NON-SBIR/STTR RPGS
Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2024 – 2025

Mycosis Fungoides (MF) is a clonal disorder of skin-resident memory T cells and is the most common form of cutaneous T-cell lymphoma (CTCL). In the early stages of MF, T cells resi...

$2.19M
USD
Completed NON-SBIR/STTR RPGS
Translation of Noninvasive Metabolic Biomarkers to Targeted Therapy for Cancer
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2025

TRANSLATION OF NONINVASIVE METABOLIC BIOMARKERS TO TARGETED THERAPY FOR CANCER PROJECT SUMMARY/ABSTRACT The genetic mutations that make a living cell become cancer produce faulty s...

$1.9M
USD
Completed NON-SBIR/STTR RPGS
Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2024 – 2025

PROJECT ABSTRACT Hodgkin Lymphoma (HL) is a cancer whose principal therapies are associated with an increased risk for cardiopulmonary complications and cerebrovascular disease whe...

$2.4M
USD
Completed NON-SBIR/STTR RPGS
Enhancing intratumoral T cell infiltration by deliver of shCXCL5 in a Plectin targeted AAV to improve checkpoint blockade efficacy
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2024 – 2025

ABSTRACT Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal disease and is expected to become the second leading cause of cancer-associated-death in the US by the year 2025...

$775K
USD
Active NON-SBIR/STTR RPGS
The pro-metastatic role of androgen receptor in estrogen receptor mutated breast cancer
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2024 – 2028

The five-year survival rate for metastatic breast cancer (MBC) remains less than 50% and nearly all patients eventually succumb to the disease; therefore, understanding pro-metasta...

$6.56M
USD
Active NON-SBIR/STTR RPGS
Activation of protein kinases by proline hydroxylation
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2024 – 2028

Project summary Eukaryotic protein kinases regulate important cellular processes through their ability to phosphorylate themselves and substrate proteins. One of the phosphorylatio...

$4.46M
USD
Active NON-SBIR/STTR RPGS
Developing PARP-1 PET with companion tissue assay as a precision tool to guide PARPi therapy
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2028

Developing PARP-1 PET with companion tissue assay as a precision tool to guide PARPi therapy PROJECT SUMMARY When we give pharmaceuticals to patients with cancer, they deserve the...

$5.22M
USD